TCON TRACON Pharmaceuticals, Inc Earnings per share trend in current year

TCON (TRACON Pharmaceuticals) - company brandmark

TRACON Pharmaceuticals (TCON) is optimizing costs by utilizing a virtual antibody development model through external contractors. The measured YoY EPS growth trend demonstrates financial resilience, with the value recorded at -28.00. ENVASARC technologies create a patent shield, although FDA certification requires significant investment. The absence of proprietary sales makes profitability dependent on the terms of B2B contracts with industry behemoths.

TCON (TRACON Pharmaceuticals, Inc.) Earnings growth in current year history from 07/04/2022 to 08/04/2024

Analytical breakdowns and data insights for company TRACON Pharmaceuticals Inc. (TCON)

Fundamental valuation:TRACON Pharmaceuticals
Manufactured products of TRACON Pharmaceuticals, Inc.

This indicator captures the year-over-year dynamics of earnings per share, reflecting cost management efficiency and the resilience of the business model. The implementation of software automation for clinical trials based on the CRO model allows TRACON Pharmaceuticals to optimize data digitization, which directly impacts the annual EPS growth profile. Analyzing this trend helps investors distinguish random fluctuations from the issuer's systemic financial progress.

Direct competitors

Tempus AI, Inc (TEM) - Earnings growth in current year|Earnings per share growth in current year Qiagen|IONS: Earnings per share increase in current year|Net earnings per share growth this year RGEN (Repligen)|Expected net earnings per share growth this year Avidity Biosciences Inc|Earnings growth in current year CRSP (crisprtx.com)|WGS: Earnings per share growth this year|RARE: Net earnings per share growth this year|Earnings per share trend in current year BEAM|Sarepta (SRPT) - Earnings per share growth in current year|TWST - Expected net earnings per share growth this year|Earnings per share growth in current year 10x Genomics, Inc.|NTLA: Earnings per share increase in current year|Net earnings per share growth this year STOK (Stoke Corp)|Expected net earnings per share growth this year biolifesolutions.com|Earnings growth in current year WVE (Wave Life Sciences Ltd)|Expected net earnings per share growth this year Maze Therapeutics (MAZE)|SION: Net earnings per share growth this year|Expected net earnings per share growth this year Prime Medicine Bio PRME|TSHA: Earnings growth in current year|Earnings per share growth this year QURE|Net earnings per share growth this year MGTX|Earnings per share growth this year RGNX (REGENXBIO)|Earnings growth in current year SLDB|OCGN - Earnings per share growth rate in current year|Earnings per share growth in current year Pacific Biosciences of California PACB|BNTC: Earnings per share growth this year|DSGN - Earnings per share growth in current year|RCKT: Earnings per share growth in current year|FDMT - Net earnings per one share growth for the current year|Earnings per share growth rate in current year Lexeo Therapeutics Inc. (LXEO)|Earnings per share growth in current year Korro Bio Inc.|Editas Medicine (EDIT) - Expected net earnings per share growth this year|Earnings per share growth in current year Silence Therapeutics Inc. (SLN)|PRQR: Earnings per share trend in current year|Earnings growth in current year CDXS (codexis.com)|SGMO: Earnings per share growth this year|NAUT: Net earnings per share growth this year|Earnings per share growth rate in current year metagenomi.co|Precision BioSciences, Inc. (DTIL) - Earnings per share growth in current year|Earnings per share growth rate in current year Generation Bio Corp (GBIO)|Net earnings per share growth this year BOLD|exicuretx.com (XCUR) - Expected net earnings per share growth this year|Net earnings per share growth this year IMNN (Celsion Corporation)|PHIO (Phio Pharmaceuticals Corp.) - Earnings per share increase in current year|Earnings growth in current year MBIO (Mustang Bio Corp)|Net earnings per one share growth for the current year RNAZ (TransCode Therapeutics)|BNGO - Earnings per share growth in current year|APDN: Earnings per share growth in current year|BLUE: Earnings growth in current year|Net earnings per share growth this year ImmunoPrecise Antibodies|OMGA (Omega Therapeutics, Inc.) - Earnings growth in current year|Singular Genomics (OMIC) - Expected net earnings per share growth this year|Earnings per share growth in current year Regulus (RGLS)|SYRS (Syros Pharmaceuticals, Inc) - Earnings per share increase in current year|Telesis Bio, Inc. - Net earnings per share growth this year|Unity Biotechnology (UBX) - Earnings per share growth rate in current year